Netherton syndrome associated with growth hormone deficiency
Tarih
2014Yazar
Darendeliler, Feyza
Bundak, Ruveyde
Saka, Nurcin
Bas, Firdevs
Ozkaya, Esen
Suleyman, Ayse
Tamay, Zeynep Ülker
Aydin, Banu Kucukemre
Kilic, Gurkan
Guler, Nermin
Üst veri
Tüm öğe kaydını gösterÖzet
Netherton syndrome (NS) is a rare autosomal recessive disorder characterized by ichthyosiform scaling, hair abnormalities, and variable atopic features. Mutations in the serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS. Growth retardation is a classic feature of NS, but growth hormone (GH) deficiency with subsequent response to GH therapy is not documented in the literature. It is proposed that a lack of inhibition of proteases due to a deficiency of LEKTI in the pituitary gland leads to the overprocessing of human GH in NS. Herein we report three patients with NS who had growth retardation associated with GH deficiency and responded well to GH therapy.
Bağlantı
http://hdl.handle.net/20.500.12627/22628https://doi.org/10.1111/pde.12220
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84891848580&origin=inward
Koleksiyonlar
- Makale [92796]